a 66-year-old female with chronic renal failure received five doses of procainamide and developed marked qt interval prolongation and recurrent episodes of torsades de pointes , which were temporally related to high serum n-acetylprocainamide ( napa ) levels and not to procainamide levels .
C0040479
torsades de pointes
C0033216
procainamide